FAST vs ZYME · P/E 43, rev $7.55B vs rev $76.3M
Fastenal Company (FAST) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the FAST and ZYME stock pages for the full models.
Not investment advice.